Unlike the TCGA (Network and The Cancer Genome Atlas Research Network, 2011) cohort, where 96% of the ovarian cancer samples showed TP53 mutation, TP53 mutation was observed only in 50% of HGSOC (2/4) samples in the Indian Cohort. The gene discussed is TP53; the disease is ovarian cancer.